We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

126 hedge funds and large institutions have $163M invested in Arena Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $415K

72% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 29

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

2% more capital invested

Capital invested by funds: $160M → $163M (+$3.06M)

2% less funds holding

Funds holding: 128 → 126 (-2)

Holders
126
Holders Change
-2
Holders Change %
-1.56%
% of All Funds
3.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
50
Reduced
29
Closed
9
Calls
$1.1M
Puts
$415K
Net Calls
+$681K
Net Calls Change
+$436K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$29.6M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.42M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.35M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$811K
5
Axa
Axa
France
+$787K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.96M
2
AC
Ascend Capital
California
-$1.21M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.07M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.03M
5
Citigroup
Citigroup
New York
-$619K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$577K +$153K +10,317 +35%
Swiss National Bank
27
Swiss National Bank
Switzerland
$564K – – –
TA
28
Teachers Advisors
New York
$562K – – –
AllianceBernstein
29
AllianceBernstein
Tennessee
$558K -$77.3K -5,220 -12%
USAA
30
United Services Automobile Association
Texas
$513K -$20.8K -1,405 -4%
Group One Trading
31
Group One Trading
Illinois
$505K -$253K -17,081 -33%
TC
32
TFS Capital
Pennsylvania
$497K +$382K +25,818 +315%
Two Sigma Investments
33
Two Sigma Investments
New York
$457K +$448K +30,242 +2,905%
QI
34
QS Investors
New York
$452K – – –
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$419K +$16K +1,079 +4%
CCMH
36
Cornerstone Capital Management Holdings
New York
$405K +$307K +20,748 +293%
ARTA
37
A.R.T. Advisors
New York
$347K +$123K +8,294 +53%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$322K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$292K +$33.9K +2,290 +13%
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$291K – – –
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$286K +$290K +19,590 New
VKH
42
Virtu KCG Holdings
New York
$283K +$132K +8,902 +85%
NCCM
43
Nine Chapters Capital Management
New Jersey
$263K +$267K +18,020 New
Wells Fargo
44
Wells Fargo
California
$259K +$1.56K +105 +0.6%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$251K +$26K +1,757 +11%
ProShare Advisors
46
ProShare Advisors
Maryland
$231K -$62.3K -4,204 -21%
AIG
47
American International Group
New York
$220K +$14.8K +996 +7%
Barclays
48
Barclays
United Kingdom
$217K +$157K +10,624 +251%
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$215K – – –
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$206K +$102K +6,897 +95%
1
2
3 4 5

ARNA Hedge Fund Activity: Q1 2017 in Review

126 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2017, worth a combined $163M — up 1.9% from $160M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARNA positions and 9 closed out — a net gain of 5 holders — while 50 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $29.6M. The largest seller was Fidelity Investments, cutting an estimated $7.96M.

  • 126 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2017, down from 128 in Q4 2016.
  • Funds reported $163M of Arena Pharmaceuticals Inc stock for Q1 2017, up 1.9% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q1 2017 and 9 closed out, a net change of +5 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2017 was BlackRock, an estimated $29.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $7.96M sold.

Based on aggregated 13F filings for Q1 2017.